{"organizations": [], "uuid": "8a363b8b486995c54b6511f8f449bce4eb39cb09", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-mimedx-postpones-release-of-fourth/brief-mimedx-postpones-release-of-fourth-quarter-results-idUSFWN1QA0L2", "country": "US", "domain_rank": 408, "title": "BRIEF-MiMedx Postpones Release Of Fourth Quarter Results", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-20T16:06:00.000+02:00", "replies_count": 0, "uuid": "8a363b8b486995c54b6511f8f449bce4eb39cb09"}, "author": "", "url": "https://www.reuters.com/article/brief-mimedx-postpones-release-of-fourth/brief-mimedx-postpones-release-of-fourth-quarter-results-idUSFWN1QA0L2", "ord_in_thread": 0, "title": "BRIEF-MiMedx Postpones Release Of Fourth Quarter Results", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-mimedx postpones release of fourth quarter results reuters", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "mimedx group inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 08 PM / in 6 minutes BRIEF-MiMedx Postpones Release Of Fourth Quarter Results Reuters Staff Feb 20 (Reuters) - Mimedx Group Inc: * MIMEDX POSTPONES RELEASE OF ITS FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS * MIMEDX - ‍BOARD ENGAGED INDEPENDENT LEGAL AND ACCOUNTING ADVISORS TO CONDUCT AN INTERNAL INVESTIGATION INTO CURRENT & PRIOR-PERIOD MATTERS​ * MIMEDX GROUP INC - ‍BOARD INVESTIGATION IS OF MATTERS RELATING TO ALLEGATIONS REGARDING CERTAIN SALES AND DISTRIBUTION PRACTICES AT COMPANY​ * MIMEDX GROUP - BASED ON INFORMATION AVAILABLE TO DATE, OUTCOME OF INTERNAL INVESTIGATION SHOULD NOT HAVE MATERIAL IMPACT ON 2018 REVENUE GUIDANCE * MIMEDX GROUP INC - ‍COMPANY EXECUTIVES ARE ALSO REVIEWING, AMONG OTHER ITEMS, ACCOUNTING TREATMENT OF CERTAIN DISTRIBUTOR CONTRACTS​ * MIMEDX GROUP - DOES NOT EXPECT DELAY IN RELEASE OF RESULTS TO AFFECT ITS OPERATIONAL PERFORMANCE AND CLINICAL RESEARCH ACTIVITIES Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-20T16:06:00.000+02:00", "crawled": "2018-02-20T16:15:58.022+02:00", "highlightTitle": ""}